| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
China Regenerative Medicine International Limited (HK: 8158)
8158 Technical Analysis
2
| As on 12th Dec 2025 8158 STOCK Price closed @ 0.44 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.48 & Strong Buy for SHORT-TERM with Stoploss of 0.31 we also expect STOCK to react on Following IMPORTANT LEVELS. |
8158STOCK Price
| Open | 0.57 | Change | Price | % |
| High | 0.57 | 1 Day | -0.11 | -20.00 |
| Low | 0.40 | 1 Week | -0.13 | -22.81 |
| Close | 0.44 | 1 Month | -0.19 | -30.16 |
| Volume | 135000 | 1 Year | 0.10 | 29.41 |
| 52 Week High 0.97 | 52 Week Low 0.26 | ||||
HK Hong Kong Most Active Stocks
| 1341 | 0.09 | 12.50% |
| 1060 | 0.86 | 3.61% |
| 0020 | 2.21 | 4.74% |
| 1359 | 1.38 | -2.82% |
| 43 | 1.14 | 0.00% |
| 0020-OL | 2.11 | -1.40% |
| 0939 | 7.64 | 0.79% |
| CSHK100 | 2317.75 | 1.82% |
| 1810 | 42.96 | 1.85% |
| 1288 | 5.55 | -2.97% |
HK Hong Kong Top Gainers Stocks
HK Hong Kong Top Losers Stocks
| 8158 Daily Charts |
8158 Intraday Charts |
Whats New @ Bazaartrend |
8158 Free Analysis |
|
|
8158 Important Levels Intraday
| RESISTANCE | 0.77 |
| RESISTANCE | 0.66 |
| RESISTANCE | 0.60 |
| RESISTANCE | 0.53 |
| SUPPORT | 0.35 |
| SUPPORT | 0.28 |
| SUPPORT | 0.22 |
| SUPPORT | 0.11 |
8158 Forecast December 2025
| 4th UP Forecast | 0.75 |
| 3rd UP Forecast | 0.65 |
| 2nd UP Forecast | 0.59 |
| 1st UP Forecast | 0.53 |
| 1st DOWN Forecast | 0.35 |
| 2nd DOWN Forecast | 0.29 |
| 3rd DOWN Forecast | 0.23 |
| 4th DOWN Forecast | 0.13 |
8158 Weekly Forecast
| 4th UP Forecast | 0.75 |
| 3rd UP Forecast | 0.65 |
| 2nd UP Forecast | 0.59 |
| 1st UP Forecast | 0.53 |
| 1st DOWN Forecast | 0.35 |
| 2nd DOWN Forecast | 0.29 |
| 3rd DOWN Forecast | 0.23 |
| 4th DOWN Forecast | 0.13 |
8158 Forecast2025
| 4th UP Forecast | 2.29 |
| 3rd UP Forecast | 1.7 |
| 2nd UP Forecast | 1.33 |
| 1st UP Forecast | 0.96 |
| 1st DOWN Forecast | -0.08 |
| 2nd DOWN Forecast | -0.45 |
| 3rd DOWN Forecast | -0.82 |
| 4th DOWN Forecast | -1.41 |
China Regenerative Medicine International Limited ( HK Hong Kong Symbol : 8158 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
8158 Business Profile
China Regenerative Medicine International Limited, an investment holding company, engages in the research and development of bio-medical and healthcare products, and medical techniques. It operates through Cell Products and Services, Cosmetic Products and Services, and Healthcare Products and Services segments. The company offers health management services, such as assessment of health situation, treatment for detox, balance of inner body, nourishing organs, and enhancement of immune system; and beauty services comprising non-surgical medical aesthetic services, basic skincare, solutions for youthful skin, hair revitalizing, lines firming, partial remodelling, and intimate repairing services. It also provides skincare and cosmetic products, including facial and eye creams, serums, moisturizing spray, tonic water, etc., under the Ascara brand. In addition, the company engages in the research and development, and applications of cell culture equipment and cell products; provision of cell-related outsourcing technical services; human cell separation, purification, cultivation, amplification, storage, and transportation; development and production of automated closed cell bioreactors; cellular therapy, cell storage, genetic testing, and biological agents manufacturing; cell preparation processes; technology platforms for clinical application transformation; developing of cell culture devices; separation, isolation, expansion, cryo-storage, and transportation of human cells; development and production of automated closed system cell expansion equipment. Further, it provides bio-engineered cornea, tissue engineering skin related products, and stem cell operation services. The company was formerly known as China Bio-Med Regeneration Technology Limited and changed its name to China Regenerative Medicine International Limited in March 2015. China Regenerative Medicine International Limited was founded in 1995 and is headquartered in Tsim Sha Tsui, Hong Kong. Address: Miramar Tower, Tsim Sha Tsui, Hong Kong
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service